| 产品名称: | Human adenovirus 36 |
|---|---|
| 商品货号: | TS199073 |
| Classification: | Adenoviridae, Mastadenovirus, Human adenovirus D |
| Agent: | Human adenovirus 36 |
| Strain: | 275 |
| Applications: | Respiratory research |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | frozen |
| Storage Conditions: | -70°C or colder |
| Comments: | Prepared from ATCC®xa0VR-913™ following treatment to remove mycoplasma contamination.
No serological cross-reaction with other human adenoviruses. Hemagglutinin active for rat and human erythrocytes. |
| Effect on Host: | CPE, typical adenovirus rounding beginning in clusters |
| Recommended Host: |
A549 (ATCC® CCL-185™)
|
| Growth Conditions: | Recommendations for Infection: For best results, plate cells 24-48 hours in advance. Infect at about 80% confluence using a multiplicity of infection (MOI) of 0.1 to 1.0. Incubate at 37°C for 3-7 days, until CPE are well advanced in 100% of the culture. A 5% CO2 in air atmosphere is recommended. |
| Name of Depositor: | R. Wigand, ATCC |
| Source: | Feces from human diabetic; derived from ATCC® VR-913™ following treatment to remove mycoplasma contamination. |
| References: | Wigand R, et al. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch. Virol. 64: 225-233, 1980. PubMed: 7406681 |